loadpatents
Patent applications and USPTO patent grants for Mendrick; Donna.The latest application filed is for "hepatotoxicity molecular models".
Patent | Date |
---|---|
Hepatotoxicity Molecular Models App 20110071767 - Porter; Mark ;   et al. | 2011-03-24 |
Myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides Grant 7,851,596 - Gentz , et al. December 14, 2 | 2010-12-14 |
Methods for determining hepatotoxins Grant 7,590,493 - Mendrick , et al. September 15, 2 | 2009-09-15 |
Molecular Toxicology Modeling App 20090220970 - Mendrick; Donna ;   et al. | 2009-09-03 |
Myeloid Progenitor Inhibitory Factor-1 (MPIF-1), Monocyte Colony Inhibitory Factor (M-CIF), and Macrophage Inhibitory Factor-4 (MIP-4) App 20080274109 - Gentz; Reiner L. ;   et al. | 2008-11-06 |
Methods for determining renal toxins Grant 7,426,441 - Mendrick , et al. September 16, 2 | 2008-09-16 |
Molecular toxicology modeling Grant 7,415,358 - Mendrick , et al. August 19, 2 | 2008-08-19 |
Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1) Grant 7,364,865 - Gentz , et al. April 29, 2 | 2008-04-29 |
Keratinocyte growth factor-2 polynucleotides Grant 7,232,667 - Ruben , et al. June 19, 2 | 2007-06-19 |
Cardiotoxin molecular toxicology modeling App 20070061086 - Mendrick; Donna ;   et al. | 2007-03-15 |
Primary rat hepatocyte toxicity modeling App 20070055448 - Mendrick; Donna ;   et al. | 2007-03-08 |
Molecular toxicology modeling App 20070043515 - Mendrick; Donna ;   et al. | 2007-02-22 |
Antibodies to monocyte-colony inhibitory factor (M-CIF) Grant 7,041,460 - Gentz , et al. May 9, 2 | 2006-05-09 |
Molecular toxicology modeling App 20060078900 - Mendrick; Donna ;   et al. | 2006-04-13 |
Keratinocyte growth factor-2 Grant 6,916,786 - Ruben , et al. July 12, 2 | 2005-07-12 |
Keratinocyte growth factor-2 Grant 6,903,072 - Ruben , et al. June 7, 2 | 2005-06-07 |
Keratinocyte growth factor-2 App 20050037966 - Ruben, Steven M. ;   et al. | 2005-02-17 |
Keratinocyte growth factor-2 App 20040224387 - Ruben, Steven M. ;   et al. | 2004-11-11 |
Human monocyte colony inhibitory factor (M-CIF) polypeptides Grant 6,811,773 - Gentz , et al. November 2, 2 | 2004-11-02 |
Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) App 20040152169 - Gentz, Reiner L. ;   et al. | 2004-08-05 |
Molecular toxicology modeling App 20040072160 - Mendrick, Donna ;   et al. | 2004-04-15 |
Keratinocyte growth factor-2 Grant 6,693,077 - Ruben , et al. February 17, 2 | 2004-02-17 |
Cardiotoxin molecular toxicology modeling App 20040014040 - Mendrick, Donna ;   et al. | 2004-01-22 |
Keratinocyte growth factor-2 App 20030186904 - Ruben, Steven M. ;   et al. | 2003-10-02 |
Therapeutic uses of keratinocyte growth factor-2 Grant 6,599,879 - Jimenez , et al. July 29, 2 | 2003-07-29 |
Keratinocyte growth factor-2 App 20030129687 - Ruben, Steven M. ;   et al. | 2003-07-10 |
Keratinocyte Growth Factor-2 App 20030077695 - RUBEN, STEVEN M. ;   et al. | 2003-04-24 |
Keratinocyte growth factor-2 Grant 6,077,692 - Ruben , et al. June 20, 2 | 2000-06-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.